oral semaglutide for obesity Drugs Edge Closer to FDA Approval, South Korea Preps US FDA accepts Novo Nordisk's

Gain insight into common side effects and strategies for managing them effectively during your treatment

When to speak to a clinician Dizziness is often mild, but persistent or severe episodes warrant medical review, especially if accompanied by fainting, confusion, very low blood pressure, chest symptoms, or irregular heart rhythm

Generic semaglutide is expected to be developed to meet regulatory standards comparable to existing formulations. Demand for GLP-1 medications has increased significantly in recent years, which has contributed to supply pressures and pricing concerns in some markets, including the United States

This is common during rapid weight loss because your body's master antioxidant glutathione gets depleted faster than it can regenerate

, Probst, M